Mats Någård
8PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 23, 2025
Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data.Jin Dong, Pradeep Sharma, Rasha Emara
|Dec 14, 2024
Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration.Jin Dong, Pradeep Sharma, Rasha Emara
|Dec 05, 2023
Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case study.Lindsay E Clegg, Lulu Chu, Mats Nagard
|Jul 02, 2023
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.Mats Någård, Mei-Lin Ah-See, James Strauss
|Jun 28, 2023
Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling.Jin Dong, Luna Prieto Garcia, Yingbo Huang
|Jun 27, 2023
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.Mats Någård, Mei-Lin Ah-See, James Strauss
Pageof 2
Frequent Collaborators
3 joint publications
Jin Dong
3 joint publications
Weifeng Tang
3 joint publications
David W Boulton
2 joint publications
Miki S Park
2 joint publications
Diansong Zhou
2 joint publications
Pradeep Sharma
2 joint publications
Rasha Emara
2 joint publications
Derek Cheung
1 joint publications
Luna Prieto Garcia
1 joint publications
Yingbo Huang
